Literature DB >> 31189528

B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency.

Benjamin Oshrine1, Nanette Grana1, Colin Moore1, Johnny Nguyen1, Melissa Crenshaw1, Melissa Edwards2, Sumedha Sudhaman2, Victoria J Forster2, Uri Tabori2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31189528      PMCID： PMC6595266          DOI： 10.1182/bloodadvances.2019000358

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  17 in total

1.  Successful matched sibling cord blood transplant for ALL in a child with constitutional mismatch repair deficiency syndrome.

Authors:  J A Heath; M Campbell; K Tiedemann; P A Downie
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

2.  CANCER. The odds of immunotherapy success.

Authors:  Matthew M Gubin; Robert D Schreiber
Journal:  Science       Date:  2015-10-09       Impact factor: 47.728

3.  Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.

Authors:  Elias Jabbour; Johannes Düll; Musa Yilmaz; Joseph D Khoury; Farhad Ravandi; Nitin Jain; Hermann Einsele; Guillermo Garcia-Manero; Marina Konopleva; Nicholas J Short; Philip A Thompson; William Wierda; Naval Daver; Jorge Cortes; Susan O'brien; Hagop Kantarjian; Max S Topp
Journal:  Am J Hematol       Date:  2017-12-23       Impact factor: 10.047

Review 4.  Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes.

Authors:  Kjeld Schmiegelow
Journal:  Eur J Med Genet       Date:  2016-02-11       Impact factor: 2.708

Review 5.  Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood.

Authors:  Uri Tabori; Jordan R Hansford; Maria Isabel Achatz; Christian P Kratz; Sharon E Plon; Thierry Frebourg; Laurence Brugières
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

Review 6.  Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.

Authors:  Harm Westdorp; Sigrid Kolders; Nicoline Hoogerbrugge; I Jolanda M de Vries; Marjolijn C J Jongmans; Gerty Schreibelt
Journal:  Cancer Lett       Date:  2017-06-20       Impact factor: 8.679

Review 7.  Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.

Authors:  Tim Ripperger; Brigitte Schlegelberger
Journal:  Eur J Med Genet       Date:  2015-12-30       Impact factor: 2.708

8.  Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

Authors:  Eric Bouffet; Valérie Larouche; Brittany B Campbell; Daniele Merico; Richard de Borja; Melyssa Aronson; Carol Durno; Joerg Krueger; Vanja Cabric; Vijay Ramaswamy; Nataliya Zhukova; Gary Mason; Roula Farah; Samina Afzal; Michal Yalon; Gideon Rechavi; Vanan Magimairajan; Michael F Walsh; Shlomi Constantini; Rina Dvir; Ronit Elhasid; Alyssa Reddy; Michael Osborn; Michael Sullivan; Jordan Hansford; Andrew Dodgshun; Nancy Klauber-Demore; Lindsay Peterson; Sunil Patel; Scott Lindhorst; Jeffrey Atkinson; Zane Cohen; Rachel Laframboise; Peter Dirks; Michael Taylor; David Malkin; Steffen Albrecht; Roy W R Dudley; Nada Jabado; Cynthia E Hawkins; Adam Shlien; Uri Tabori
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

9.  Deciphering signatures of mutational processes operative in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Peter J Campbell; Michael R Stratton
Journal:  Cell Rep       Date:  2013-01-10       Impact factor: 9.423

Review 10.  Hypermutation and microsatellite instability in gastrointestinal cancers.

Authors:  Kizuki Yuza; Masayuki Nagahashi; Satoshi Watanabe; Kazuaki Takabe; Toshifumi Wakai
Journal:  Oncotarget       Date:  2017-12-01
View more
  3 in total

Review 1.  Antibiotics in early life and childhood pre-B-ALL. Reasons to analyze a possible new piece in the puzzle.

Authors:  T M Cardesa-Salzmann; A Simon; N Graf
Journal:  Discov Oncol       Date:  2022-01-10

2.  Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition.

Authors:  Brittany B Campbell; Melissa A Galati; Simone C Stone; Alexandra N Riemenschneider; Melissa Edwards; Sumedha Sudhaman; Robert Siddaway; Martin Komosa; Nuno M Nunes; Liana Nobre; A Sorana Morrissy; Matthew Zatzman; Michal Zapotocky; Lazar Joksimovic; Sangeetha N Kalimuthu; David Samuel; Gary Mason; Eric Bouffet; Daniel A Morgenstern; Melyssa Aronson; Carol Durno; David Malkin; John M Maris; Michael D Taylor; Adam Shlien; Trevor J Pugh; Pamela S Ohashi; Cynthia E Hawkins; Uri Tabori
Journal:  Cancer Discov       Date:  2021-02-09       Impact factor: 39.397

3.  Toward prevention of childhood ALL by early-life immune training.

Authors:  Julia Hauer; Ute Fischer; Arndt Borkhardt
Journal:  Blood       Date:  2021-10-21       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.